Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill shows promise for controlling acromegaly Long-Term

NCT ID NCT04261712

Terminated Disease control Sponsor: Crinetics Pharmaceuticals Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 4 times

Summary

This study looks at the long-term safety and effectiveness of an oral medication called paltusotine for people with acromegaly, a condition where the body makes too much growth hormone. About 43 adults who finished a previous related study will take the drug and be monitored for side effects and hormone levels. The goal is to see if paltusotine can safely control the disease over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acromegaly

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACROMEGALY

Contacts and locations

Locations

  • Crinetics Study Site

    Los Angeles, California, 90095, United States

  • Crinetics Study Site

    Chicago, Illinois, 60611, United States

  • Crinetics Study Site

    Boston, Massachusetts, 02114, United States

  • Crinetics Study Site

    Columbus, Ohio, 43210, United States

  • Crinetics Study Site

    Pittsburgh, Pennsylvania, 15212, United States

  • Crinetics Study Site

    Pittsburgh, Pennsylvania, 15213, United States

  • Crinetics Study Site

    Dallas, Texas, 75231, United States

  • Crinetics Study Site

    Curitiba, Paraná, 80030-110, Brazil

  • Crinetics Study Site

    Rio de Janeiro, 20231, Brazil

  • Crinetics Study Site

    Rio de Janeiro, 21941, Brazil

  • Crinetics Study Site

    São Paulo, 01228, Brazil

  • Crinetics Study Site

    München, 80336, Germany

  • Crinetics Study Site

    Athens, 10676, Greece

  • Crinetics Study Site

    Thessaloniki, 54642, Greece

  • Crinetics Study Site

    Budapest, 1062, Hungary

  • Crinetics Study Site

    Budapest, 1083, Hungary

  • Crinetics Study Site

    Pécs, 7624, Hungary

  • Crinetics Study Site

    Belgrade, 11000, Serbia

  • Crinetics Study Site

    Coventry, United Kingdom

  • Crinetics Study Site

    Leeds, LS97TF, United Kingdom

  • Crinetics Study Site 1

    Athens, 11527, Greece

  • Crinetics Study Site 2

    Athens, 11527, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.